Sangamo Biosciences (SGMO) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -5.7%
Financial Fact:
Loss from operations: -19.21M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q4 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $9.86 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
- Morgan Stanley Downgrades Melco Resorts (MLCO) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
